DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

AM Starzer, G Heller, E Tomasich, Thomas Melchardt (Co-author), K Feldmann, T Hatziioannou, S Traint, C Minichsdorfer, U Schwarz-Nemec, M Nackenhorst, L Mullauer, M Preusser, AS Berghoff, T Fuereder

Research output: Contribution to journalOriginal Article (Journal)peer-review

12 Citations (Web of Science)
Original languageEnglish
Pages (from-to)e003420
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume10
Issue number3
DOIs
Publication statusPublished - 2022

Keywords

  • CLASSIFICATION
  • IMMUNOTHERAPY
  • NIVOLUMAB
  • RECURRENT
  • PEMBROLIZUMAB
  • EXPRESSION
  • CETUXIMAB
  • PROMOTER
  • CANCERS
  • SYSTEM

Cite this